Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients

Published:2011-10 Issue:1 Volume:74 Page:124-131
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kato Tatsuya,Daigo Yataro,Aragaki Masato,Ishikawa Keidai,Sato Masaaki,Kondo Satoshi,Kaji Mitsuhito

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Cancer statistics, 2001;Greenlee;CA Cancer J Clin,2001

2. Molecular biology of lung cancer;Sozzi;Eur J Cancer,2001

3. The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint;De Antoni;Curr Biol,2005

4. Gene expression patterns in human liver cancers;Chen;Mol Biol Cell,2002

5. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma;Zhang;Hum Pathol,2008

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan-based smart stimuli-responsive nanoparticles for gene delivery and gene therapy: Recent progresses on cancer therapy;International Journal of Biological Macromolecules;2024-10

2. Smart Physicochemical-triggered Chitosan-based Nanogels for siRNA Delivery and Gene Therapy: A Focus on Emerging Strategies and Paradigms for Cancer Therapy;Current Medicinal Chemistry;2024-06-05

3. Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples;Oncotarget;2024-02-05

4. The Anaphase-Promoting Complex/Cyclosome Is a Cellular Ageing Regulator;International Journal of Molecular Sciences;2022-12-05

5. Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect;OncoTargets and Therapy;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3